Optimizing drug delivery to the lymphatic system is essential for effective cancer treatment, as lymph node (LN) metastasis ...

Lymphatic Drug Delivery System (LDDS) is an emerging type of cancer treatment, but its efficacy depends on how efficiently ...

Breakthrough research presented at the 2026 Society of Thoracic Surgeons Annual Meeting shows that additional lymph node ...

Stanford University-led researchers report that tumor cells hijack mitochondria from immune cells, reducing anti-tumor immune function and activating cGAS-STING and type I interferon signaling that ...

Images below confirm clinical responses seen in patients with metastatic orbital (eye), temporal (brain), liver, and spine ...

Introduction Accurate preoperative assessment of lymph node metastasis (LNM) is a key determinant of treatment selection in early gastric cancer (EGC), particularly when choosing between endoscopic ...

Metastatic urothelial carcinoma has a poor prognosis: ~50% of muscle-invasive bladder cancer progresses to metastasis, and ...

Using PROTECT trial data, investigators assessed the possible benefit of early treatment vs active monitoring for cribriform-positive prostate cancer.

Various imaging modalities show low sensitivity for detecting pelvic lymph node invasion prior to surgery in patients with intermediate risk prostate cancer.

Metastasis and disease progression remain the leading causes of mortality in both breast and cervical cancer. These processes ...

Veterinary Oncologist Successfully Imports EMA-Approved Tyrosine Kinase Inhibitor for Metastatic Mast Cell Tumor VMD Sciences, the leader in global veterinary pharmaceutical access services, announced ...